Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEREV: Remimazolam vs Propofol for One-Lung Ventilation Anesthesia
jRCT1031210446Recruiting
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of remimazolam in lung neoplasm and Perioperative respiratory compromise (PRC) (2 arms). Primary endpoint: Frequency and degree of hypoxemia. Started Dec 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
lung neoplasmPerioperative respiratory compromise (PRC)
Beyond the preview
Go deeper on jRCT1031210446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031210446.